Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2004
10/21/2004WO2004089931A1 Substituted pyrazoles
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004WO2004089926A2 Genipin derivatives and uses thereof
10/21/2004WO2004089925A1 Pi-3 kinase inhibitor prodrugs
10/21/2004WO2004089922A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine
10/21/2004WO2004089919A1 Cyclohexanecarboxamido derivative
10/21/2004WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof
10/21/2004WO2004089917A2 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome
10/21/2004WO2004089908A2 3-azabicyclo[3.2.1]octane derivatives
10/21/2004WO2004089901A2 Phospholipase c inhibitors for use in treating inflammatory disorders
10/21/2004WO2004089896A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/21/2004WO2004089895A1 Process for the preparation of amorphous calcium salt of atorvastatin
10/21/2004WO2004089893A1 Substance exhibiting antidepressant property
10/21/2004WO2004089887A1 Process for the production of 9-cis retinoic acid
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089880A2 Carbamates useful as fragances
10/21/2004WO2004089872A1 Highly pure bases of 3,3-diphenyl propylamine monoesters
10/21/2004WO2004089471A2 NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
10/21/2004WO2004089470A2 New amide derivatives and pharmaceutical use thereof
10/21/2004WO2004089427A1 Stable carprofen composition
10/21/2004WO2004089419A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody
10/21/2004WO2004089418A1 A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid
10/21/2004WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same
10/21/2004WO2004089414A2 Combinations of proton pump inhibitors or blockers with prokinetic agents
10/21/2004WO2004089412A1 Specific nad(p)h oxidase inhibitor
10/21/2004WO2004089410A1 Preventive and/or remedy for neuropathic pain
10/21/2004WO2004089407A2 Zwitterionic immunomodulators for the treatment of asthma and allergy
10/21/2004WO2004089396A2 Anti-fungal peptidomimetics
10/21/2004WO2004089395A2 Use of an inhibitor of cathepsin-s or -b to treat or prevent chronic obstructive pulmonary disease
10/21/2004WO2004089392A1 Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
10/21/2004WO2004089388A1 The ready-prepared chinese medicine for treatment of hair loss and process of manufacturing thereof
10/21/2004WO2004089383A1 Pharmaceutical combinations comprising lamivudine, stavudine and efavirenz for treating viral infections
10/21/2004WO2004089382A1 Pharmaceutical combinations comprising lamivudine, zidovudine and efavirenz for treating viral infections
10/21/2004WO2004089381A1 Prostaglandin compositions and their use for the treatment of vasospasm
10/21/2004WO2004089380A2 Pharmaceutical use of fused 1,2,4-triazoles
10/21/2004WO2004089379A2 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug
10/21/2004WO2004089378A1 Medicinal composition containing pyrrolopyridazine derivative
10/21/2004WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties
10/21/2004WO2004089376A2 Identification and targeting of consensus sites by which dynorphin exerts its neurotoxic effects enables analgesia without neurotoxicity
10/21/2004WO2004089375A1 Implantable polymeric device for sustained release of dopamine agonist
10/21/2004WO2004089374A1 Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
10/21/2004WO2004089372A1 Substituted 4-phenyl-4-`1h-imidazol-2-yl !-piperidine derivatives and their use as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity
10/21/2004WO2004089371A1 Treatment of addiction
10/21/2004WO2004089370A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors
10/21/2004WO2004089369A2 Methods and means for treating protein conformational disorders
10/21/2004WO2004089368A1 Therapeutic or preventive agent for dermatitis
10/21/2004WO2004089367A1 Pharmaceutical use of substituted 1,2,4-triazoles
10/21/2004WO2004089365A1 Pharmaceutical combination comprising eletriptan and sodium bicarbonate
10/21/2004WO2004089363A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004WO2004089361A1 Therapeutic patch with polysiloxane matrix comprising capsaicin
10/21/2004WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/21/2004WO2004089359A1 Composition for inhibition or prevention of bone density lowering and refreshment therefor
10/21/2004WO2004089358A1 Sclerosing solution
10/21/2004WO2004089357A2 Anti-fungal formulation of triterpene and essential oil
10/21/2004WO2004089356A2 Targeted bone marrow protection agents
10/21/2004WO2004089355A2 Compositions for treating microbial and parasitic infections in cattle and other animals
10/21/2004WO2004089353A2 Methods for treatment of parkinson's disease
10/21/2004WO2004089352A2 Pharmaceutical combination for the treatment of spasticity and/or pain
10/21/2004WO2004089351A2 Treatment of progressive neurological disorders comprising a mao inhibitor (miclobemid) and an acetylcholinesterase inhibitor (tacrin)
10/21/2004WO2004089350A1 Use of an ibat inhibitor for the treatment of prophylaxis of constipation
10/21/2004WO2004089349A2 Use of an alpha2-adrenoceptor antagonist for the treatment of epilepsy
10/21/2004WO2004089348A2 Use of a serotonin transporter inhibitor for the treatment of pulmonary hypertension
10/21/2004WO2004089347A1 Transdermal absorption preparation containing tulobuterol and patch using the same
10/21/2004WO2004089346A1 Transdermal administration of (r)-3,3-diphenylpropylamine monoesters
10/21/2004WO2004089345A1 Bone targeting of biodegradable drug-containing nanoparticles
10/21/2004WO2004089343A1 Water soluble tablets
10/21/2004WO2004089342A2 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic exipient
10/21/2004WO2004089341A1 Organic compounds
10/21/2004WO2004089340A1 Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans
10/21/2004WO2004089338A1 A arbidol clathrate and its preparation process and the use thereof
10/21/2004WO2004089334A2 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
10/21/2004WO2004089333A2 A stable benzimidazole formulation
10/21/2004WO2004089329A2 Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
10/21/2004WO2004089313A2 Novel olanzapine forms and related methods of treatment
10/21/2004WO2004089312A2 New piperidinylamino-thieno[2,3-d] pyrimidine compounds
10/21/2004WO2004089311A2 Polymeric drug agents for the treatment of fibrotic disorders
10/21/2004WO2004089309A2 Conposition and methods for inhibiting fungal growth and transference
10/21/2004WO2004089308A2 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
10/21/2004WO2004089307A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
10/21/2004WO2004089306A2 Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
10/21/2004WO2004089304A2 Antiandrogens with marginal agonist activity and methods of use
10/21/2004WO2004089300A2 Sapphyrins and uses thereof
10/21/2004WO2004089298A2 5-htp composition
10/21/2004WO2004089296A2 Improved inhibitors for the soluble epoxide hydrolase
10/21/2004WO2004089294A2 Compositions, methods and kits relating to her-2 cleavage
10/21/2004WO2004089293A2 Hydroxamic acid compounds and methods of use thereof
10/21/2004WO2004089291A2 Tumor-targeting drug-loaded particles
10/21/2004WO2004089289A2 Treating or preventing hot flashes using prodrugs of gaba analogs
10/21/2004WO2004089288A2 Method of treating lower urinary tract disorders
10/21/2004WO2004089286A2 Novel compounds and compositions as protein kinase inhibitors
10/21/2004WO2004089281A2 Novel polymorphs of tolterodine tartrate
10/21/2004WO2004089239A2 Topical anthelmintic veterinary formulations
10/21/2004WO2004089117A1 Food and drink having reduced digestibility and process for producing the same
10/21/2004WO2004089115A1 Synbiotic combination
10/21/2004WO2004089114A1 Preparations for oral administration containing physiologically active fatty acids and oligomer proanthocyanidin
10/21/2004WO2004076407A3 Pyrrolidine derivatives as oxytocin antagonists
10/21/2004WO2004075900A3 Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent
10/21/2004WO2004075824A3 Pharmaceutical compositions for nasal delivery
10/21/2004WO2004075817A3 Suspendable pharmaceutical composition
10/21/2004WO2004074350A3 Bicalutamide polymorphs
1 ... 4916 4917 4918 4919 4920 4921 4922 4923 4924 4925 4926 4927 4928 4929 4930 4931 4932 4933 4934 4935 4936 ... 7860